Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-03

FDA Approved: HALOPERIDOL DECANOATE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved haloperidol decanoate, a long-acting injectable antipsychotic, under an original application filed by Somerset Therapeutics, LLC, for the treatment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

ORIG AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)